Omai Garner PhD
Contact Information
Omai Garner, PhD
UCLA Path & Lab Med
10833 Le Conte Avenue, A7-149 CHS
Los Angeles, CA 90095
310-206-6329
Academic Title
Professor, Pathology and Laboratory Medicine
Bio
Dr. Omai Garner is a Clinical Professor and Director of Clinical Microbiology in the UCLA Health System. He received his PhD from UC San Diego in Biomedical Sciences. He was a Postdoctoral Clinical Microbiology CPEP Fellow in the Department of Pathology at UCLA, and a former McNair Scholar. Dr. Garner is Board Certified by the American Board of Medical Microbiology. Dr. Garner's research focuses on novel Point of Care Devices for infectious disease diagnosis in LMICs.
Dr. Garner was always taught that science, at its best, is a collaborative process. "It is collaboration, and not competition, which produces the most significant advances in biomedical research."
He also serves as the Chairman of the Board for the Social Justice Learning Institute of Inglewood, California.
Publications
Goncharov A, Joung HA, Ghosh R, Han GR, Ballard ZS, Maloney Q, Bell A, Aung CTZ, Garner OB, Carlo DD, Ozcan A. (2023). Deep learning enabled multiplexed point of care sensor using a paper based fluorescence vertical flow assay. Small. Dec;19(51).
Magaki S, Zhang T, Han K, Hilda M, Yong WH, Achim C, Fishbein G, Fishbein MC, Garner O, Salamon N, Williams CK, Valdes-Sueiras MA, Hsu JJ, Kelesidis T, Mathisen GE, Lavretsky H, Singer EJ, Vinters HV. (2024). HIV and COVID-19: two pandemics with significant (but different) central nervous system complications. Free Neuropathology. Mar 5;5:5-5.
Berdahl CT, Krishnadasan A, Pathmarajah K, Moran GJ, Torres JR, Waxman M, Mower W, Garner OB, Duvergne LP, Rimoin AW, Gorbach PM, Talan DA; EMERGEncy ID NET Study Group. (2024). Mpox surveillance based on rash characteristics – 13 emergency departments, United States, June-December 2023. MMWR Morbitidy and Mortality Weekly Report. Jun 6;73(22):507-513.
Ghosh R, Joung HA, Goncharov A, Palanisamy B, Ngo K, Pejcinovic K, Krockenberger N, Horn EJ, Garner OB, Ghazal E, O'Kula A, Arnaboldi PM, Dattwyler RJ, Ozcan A, Di Carlo D. (2024). Rapid single-tier serodiagnosis of lyme disease. Nature Communications. Aug 20;15(1):7124.
Ogawa L, Multani A, Beaird OE, Gaynor P, Carlson M, Garner OB, Schiller G, Schaenman JM. (2024). Risk factors and outcomes of Mucorales infection in a modern cohort of solid organ transplant, hematopoietic cell transplant, and chimeric antigen receptor T-cell therapy recipients. Transplantation proceedings. Sep;56(7):1683-1690.
Han GR, Goncharov A, Eryilmaz M, Joung HA, Ghosh R, Yim G, Chang N, Kim M, Ngo K, Veszpremi M, Liao K, Garner OB, Di Carlo D, Ozcan A. (2024). Depp learning-enhanced paper-based vertical flow assay for high-sensitivity troponin detection using nanoparticle amplification. ACS nano. Oct 15:18(41):27933-27948.
Cheng MY, Chea PD, Latifi G, Garner OB, Deng SX, Fung SSM. (2024). Microbiology profiles and antibiotic susceptibility in pediatric microbial keratitis. Cornea. Dec 10.
Işıl Ç, Koydemir HC, Eryilmaz M, de Haan K, Pillar N, Mentesoglu K, Unal AF, Rivenson Y, Chandrasekaran S, Garner OB, Ozcan A. (2025). Virtual gram staining of label-free bacteria using dark-field microscopy and deep learning. Science advances. Jan 10;11(2):eads2757.
Kaur I, Shaw B, Multani A, Pham C, Malhotra S, Smith E, Adachi K, Allyn P, Bango Z, Beaird OE, Caldera JR, Chandrasekaran S, Chan L, Cheema R, Daouk S, Deville J, Dong HV, Fan A, Garner O, Gaynor P, Gray H, Gorin A, Kalava S, Kanatani M, Karnaze A, Saleh T, Sharma Y, Stauber S, Vargas M, Veral M, Winston D, Yanagimoto-Ogawa L, Aldrovandi G, Nielsen-Saines K, Fuller T, Jackson N, Uslan D, Schaenman J, Vijayan T, Sakona A, Yang S. (2025). Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay. Infection Control and Hospital Epidemiology. Jan 30:1-8.
Smith EA, Javier GM, Multani A, Beaird OE, Gaynor P, Yanagimoto-Ogawa L, Schaenman J, Allyn P, Alfarhat G, Vijayan T, Ziman A, Garner O. (2025). Anti-SARS-CoV-2 IgG antibody titers in contemporary lots of intravenous immune globulin and fresh frozen plamsa compared to COVID convalescent plasma. Clinical Infectious Diseases. Feb 3:ciaf045.
Han GR, Goncharov A, Eryilmaz M, Ye S, Joung HA, Ghosh R, Ngo E, Tomoeda A, Lee Y, Ngo K, Melton E, Garner OB, Di Carlo D, Ozcan A. (2025). Deep learning-enhanced chemiluminescence vertical flow assay for high-sensitivity cardiac troponin I testing. Small. Feb 5:e2411585.
Garrigues JM, Gray HK, Ison RP, Uslan DZ, Lima A, Gonzalez-Ferrer S, Trejo M, Zhuo R, Matysiak Match CJ, Ulloa ER, Bhaurla S, Lewis V, Parti U, Sandoval T, Turay S, Walton S, Prabaker K, Garner OB, Chandrasekaran S, Green NM, Yang S. (2025). Outbreak of New Delhi metallo-B-lactamase carbapenemase-producing Pseudomonas aeruginosa infections in a Southern California hospital. American Journal of Infection Control. June 13:S0196.
Doseeva V, Mostafa HH, Rhoads D, Relich RF, Garner O, Findeisen P, Eigner U, English A, Johnson S. (2025). Performance evaluation of the NeuMoDx EBV Quant Assay 2.0 in comparison with cobas EBV for Epstein-barr virus DNA quantification in immunocompromised patients, a multicenter study. Diagnostic Microbiology and Infectious Disease. June 19;113(3).